Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2016 Filed Jan 28, 2016 23:57 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
GrantRestricted Stock Unit · Derivative | 6,659 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000278 · wf-form4_145402543930711.xml · derivative · entry 3 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,659 Underlying: Common Stock · 6,659 shares Expires 2017-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2016 Filed Jan 28, 2016 23:57 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
GrantCommon Stock | 7,035 | $81.96 | $576,588.60 |
DisclosureSEC source: 0000059478-16-000278 · wf-form4_145402543930711.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,101 Read SEC document |
| January 26, 2016 Filed Jan 29, 2016 00:02 UTC |
Zakrowski Donald AChief Accounting Officer
|
GrantCommon Stock | 2,003 | $81.96 | $164,165.88 |
DisclosureSEC source: 0000059478-16-000279 · wf-form4_145402572876779.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,849 Read SEC document |
| December 31, 2015 Filed Jan 4, 2016 21:19 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 115 | $86.04 | $9,894.60 |
DisclosureSEC source: 0000059478-16-000229 · wf-form4_145194236870313.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,552 Read SEC document |
| December 21, 2015 Filed Dec 22, 2015 19:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 205,000 | $86.00 | $17,630,000.00 |
DisclosureSEC source: 0001209191-15-086568 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,860,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.50 to $86.43, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 17, 2015 Filed Jan 25, 2016 20:48 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
GiftCommon Stock | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000245 · wf-form5_145375492583852.xml · nonDerivative · entry 3 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,933 Read SEC document |
| December 15, 2015 Filed Dec 16, 2015 20:06 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 215,000 | $85.60 | $18,402,925.00 |
DisclosureSEC source: 0001209191-15-085541 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,065,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.12 to $85.955, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 11, 2015 Filed Jan 25, 2016 20:45 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000243 · wf-form5_145375472634016.xml · nonDerivative · entry 5 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 329,140 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 11, 2015 Filed Jan 5, 2017 21:02 UTC Amendment |
Rice Derica WEVP-Global Services and CFO
|
OtherCommon Stock | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000006 · wf-form5a_148365010374140.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 329,206 F1 · kind: This transaction is being amended to correct the initial gift transaction, which was inadvertently distributed to the wrong recipient. The shares were returned to the account. F1 · acquired: This transaction is being amended to correct the initial gift transaction, which was inadvertently distributed to the wrong recipient. The shares were returned to the account. F2 · balance_after: Amended to correct the total holdings indirectly held by the reporting persons wife prior to this transaction. F3 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| December 09, 2015 Filed Dec 10, 2015 19:09 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
SaleCommon Stock | 25,000 | $83.88 | $2,097,000.00 |
DisclosureSEC source: 0000059478-15-000225 · wf-form4_144977454120447.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,131 F1 · price: This transaction was executed in multiple trades at prices ranging from $83.66 to $84.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 02, 2015 Filed Dec 3, 2015 18:23 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 64,715 | $85.58 | $5,538,439.13 |
DisclosureSEC source: 0001209191-15-083119 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,280,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.43 to $86.08, inclusive. Read SEC document |
| December 02, 2015 Filed Dec 3, 2015 18:23 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 145,285 | $84.87 | $12,330,628.52 |
DisclosureSEC source: 0001209191-15-083119 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,345,519 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.43 to $85.425, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 02, 2015 Filed Jan 25, 2016 20:45 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 11,596 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000243 · wf-form5_145375472634016.xml · nonDerivative · entry 4 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 329,206 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 19:11 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 1,907 | $81.23 | $154,905.61 |
DisclosureSEC source: 0000059478-15-000201 · wf-form4_144908348977786.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,272 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 19:55 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000203 · wf-form4_144908614733356.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,331 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 19:58 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000205 · wf-form4_144908629488778.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,107 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:04 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000207 · wf-form4_144908663667596.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,999 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:18 UTC |
HORN KAREN NDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000209 · wf-form4_144908747287070.xml · nonDerivative · entry 1 HORN KAREN N · CIK 0001136550 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,166 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:20 UTC |
HOOVER R DAVIDDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000211 · wf-form4_144908760419555.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,610 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:23 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000213 · wf-form4_144908776941175.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,930 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:28 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000215 · wf-form4_144908810231265.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,586 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:30 UTC |
PRENDERGAST FRANKLYN GDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000217 · wf-form4_144908823239151.xml · nonDerivative · entry 1 PRENDERGAST FRANKLYN G · CIK 0001233256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,139 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 20:34 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000219 · wf-form4_144908845080020.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,976 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 21:10 UTC |
SEIFERT KATHI PDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000221 · wf-form4_144909061601715.xml · nonDerivative · entry 1 SEIFERT KATHI P · CIK 0001222893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,099 Read SEC document |
| November 30, 2015 Filed Dec 2, 2015 21:12 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 1,785 | $81.23 | $144,995.55 |
DisclosureSEC source: 0000059478-15-000223 · wf-form4_144909074647780.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,301 Read SEC document |
| November 25, 2015 Filed Jan 25, 2016 20:27 UTC |
Harrington Michael JSenior VP and General Counsel
|
GiftCommon Stock | 2,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000236 · wf-form5_145375365149434.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,082 Read SEC document |
| November 23, 2015 Filed Nov 25, 2015 19:57 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 9,036 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-15-000199 · wf-form4_144848143163832.xml · derivative · entry 6 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,036 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2015 Filed Nov 25, 2015 19:57 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Tax withholdingCommon Stock | 7,434 | $84.47 | $627,949.98 |
DisclosureSEC source: 0000059478-15-000199 · wf-form4_144848143163832.xml · nonDerivative · entry 2 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,409 Read SEC document |
| November 23, 2015 Filed Nov 25, 2015 19:57 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 9,036 | $56.18 | $507,642.48 |
DisclosureSEC source: 0000059478-15-000199 · wf-form4_144848143163832.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 20:45 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 12,048 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-15-000197 · wf-form4_144831152291512.xml · derivative · entry 4 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,048 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 20:45 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
Tax withholdingCommon Stock | 9,674 | $83.72 | $809,907.28 |
DisclosureSEC source: 0000059478-15-000197 · wf-form4_144831152291512.xml · nonDerivative · entry 2 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,066 Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 20:45 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
Exercise / conversionCommon Stock | 12,048 | $56.18 | $676,856.64 |
DisclosureSEC source: 0000059478-15-000197 · wf-form4_144831152291512.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 18:06 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,300 | $85.32 | $1,561,429.20 |
DisclosureSEC source: 0001209191-15-081732 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,490,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.145 to $85.495, inclusive. Read SEC document |
| November 20, 2015 Filed Nov 23, 2015 18:06 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 186,700 | $84.47 | $15,769,802.20 |
DisclosureSEC source: 0001209191-15-081732 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,509,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.12 to $85.11, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 13, 2015 Filed Jan 25, 2016 20:36 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
GiftCommon Stock | 10,808 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000239 · wf-form5_145375416737661.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642,549 Read SEC document |
| November 12, 2015 Filed Nov 16, 2015 20:51 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 6,928 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-15-000193 · wf-form4_144770710752228.xml · derivative · entry 4 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,928 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2015 Filed Nov 16, 2015 20:51 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Tax withholdingCommon Stock | 5,579 | $80.70 | $450,225.30 |
DisclosureSEC source: 0000059478-15-000193 · wf-form4_144770710752228.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,131 Read SEC document |
| November 12, 2015 Filed Nov 16, 2015 20:51 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionCommon Stock | 6,928 | $56.18 | $389,215.04 |
DisclosureSEC source: 0000059478-15-000193 · wf-form4_144770710752228.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2015 Filed Jan 25, 2016 20:39 UTC |
Mahony SusanSVP & Pres., Lilly Oncology
|
GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000241 · wf-form5_145375438646216.xml · nonDerivative · entry 2 Mahony Susan · CIK 0001463321 · SVP & Pres., Lilly Oncology 10b5-1 filing: Not disclosed Ownership: Indirect · by husband Disclosed balance after: 8,384 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| November 05, 2015 Filed Nov 9, 2015 21:33 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 4,970 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-15-000184 · wf-form4_144710480852147.xml · derivative · entry 4 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,970 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2015 Filed Nov 9, 2015 21:33 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Tax withholdingCommon Stock | 3,924 | $81.05 | $318,040.20 |
DisclosureSEC source: 0000059478-15-000184 · wf-form4_144710480852147.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,184 Read SEC document |
| November 05, 2015 Filed Nov 9, 2015 21:33 UTC |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Exercise / conversionCommon Stock | 4,970 | $56.18 | $279,214.60 |
DisclosureSEC source: 0000059478-15-000184 · wf-form4_144710480852147.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2015 Filed Nov 16, 2015 20:54 UTC Amendment |
Ricks David ASVP and Pres, Lilly Bio-Meds
|
Tax withholdingCommon Stock | 3,908 | $81.05 | $316,743.40 |
DisclosureSEC source: 0000059478-15-000195 · wf-form4a_144770726103620.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,200 F1 · shares: This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. F1 · balance_after: This amendment is being filed to correctly report the amount disposed in column 4, and to correct the number of securities beneficially owned following the reported transaction, as reported in column 5. Read SEC document |
| November 03, 2015 Filed Nov 5, 2015 18:53 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionEmployee stock option 2/06 (right to buy) · Derivative | 70,964 | $0.00 Strike: $56.18 | $0.00 |
DisclosureSEC source: 0000059478-15-000182 · wf-form4_144674957339313.xml · derivative · entry 10 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,964 shares Expires 2016-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2015 Filed Nov 5, 2015 18:53 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 58,853 | $82.04 | $4,828,300.12 |
DisclosureSEC source: 0000059478-15-000182 · wf-form4_144674957339313.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,312 Read SEC document |
| November 03, 2015 Filed Nov 5, 2015 18:53 UTC |
LECHLEITER JOHN CDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 70,964 | $56.18 | $3,986,757.52 |
DisclosureSEC source: 0000059478-15-000182 · wf-form4_144674957339313.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2015 Filed Nov 3, 2015 20:07 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 124 | $80.25 | $9,951.00 |
DisclosureSEC source: 0000059478-15-000177 · wf-form4_144658126338944.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,365 Read SEC document |
| October 29, 2015 Filed Oct 30, 2015 19:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,500 | $83.43 | $876,025.50 |
DisclosureSEC source: 0001209191-15-077406 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,695,804 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.35 to $83.55, inclusive. Read SEC document |
| October 29, 2015 Filed Oct 30, 2015 19:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 92,269 | $82.75 | $7,635,536.56 |
DisclosureSEC source: 0001209191-15-077406 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,706,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.35 to $83.34, inclusive. Read SEC document |
| October 29, 2015 Filed Oct 30, 2015 19:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 97,231 | $81.70 | $7,944,161.62 |
DisclosureSEC source: 0001209191-15-077406 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,798,573 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.315 to $82.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.